BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 27138072)

  • 1. CT halo sign and crazy paving pattern due to lung metastases hemorrhage after sunitinib therapy.
    De Wulf S; Coulier B; Rezazadeh Azar A; Clausse M; Van Cutsem O; Frognier R
    Diagn Interv Imaging; 2017 Jan; 98(1):93-95. PubMed ID: 27138072
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe rhabdomyolysis during sunitinib treatment of metastatic renal cell carcinoma. A report of two cases.
    Ruggeri EM; Cecere FL; Moscetti L; Doni L; Padalino D; Di Costanzo F
    Ann Oncol; 2010 Sep; 21(9):1926-1927. PubMed ID: 20729535
    [No Abstract]   [Full Text] [Related]  

  • 3. Fatigue with sunitinib-induced hypothyroidism.
    Senior K
    Lancet Oncol; 2007 Feb; 8(2):101. PubMed ID: 17288042
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment with sunitinib and hypothyroidism--a case report and overview of literature].
    Kreze A; Stáhalová V; Zadrazilová A; Koskuba J; Kosák M
    Klin Onkol; 2009; 22(4):176-8. PubMed ID: 19731880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sunitinib inducing tumor lysis syndrome in a patient treated for renal carcinoma.
    Michels J; Lassau N; Gross-Goupil M; Massard C; Mejean A; Escudier B
    Invest New Drugs; 2010 Oct; 28(5):690-3. PubMed ID: 19547920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour lysis syndrome in a patient with renal-cell carcinoma treated with sunitinib malate.
    Nicholaou T; Wong R; Davis ID
    Lancet; 2007 Jun; 369(9577):1923-4. PubMed ID: 17560435
    [No Abstract]   [Full Text] [Related]  

  • 7. Lower limbs erosions induced by sunitinib.
    Kluger N; Chapelle A; Jacot W; Guillot B
    Acta Derm Venereol; 2011 May; 91(3):360-1. PubMed ID: 21103845
    [No Abstract]   [Full Text] [Related]  

  • 8. Fatal liver failure in a patient treated with sunitinib for renal cell carcinoma.
    Mermershtain W; Lazarev I; Shani-Shrem N; Ariad S
    Clin Genitourin Cancer; 2013 Mar; 11(1):70-2. PubMed ID: 23063577
    [No Abstract]   [Full Text] [Related]  

  • 9. Sunitinib and hypothyroidism.
    Wolter P; Dumez H; Schöffski P
    N Engl J Med; 2007 Apr; 356(15):1580; author reply 1580-1. PubMed ID: 17429091
    [No Abstract]   [Full Text] [Related]  

  • 10. Metastatic renal cell carcinoma complicated with diffuse alveolar hemorrhage: a rare adverse effect of sunitinib.
    Yamada T; Ohtsubo K; Izumi K; Takeuchi S; Mouri H; Yamashita K; Yasumoto K; Ghenev P; Kitagawa S; Yano S
    Int J Clin Oncol; 2010 Dec; 15(6):638-41. PubMed ID: 20602135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rectal perforation after two years of treatment with sunitinib for metastatic kidney cancer.
    Bladé JS; Bourgouin S; Romeo É; Boudin L; de Jauréguiberry JP
    Presse Med; 2014 Nov; 43(11):1293-5. PubMed ID: 24999082
    [No Abstract]   [Full Text] [Related]  

  • 12. Posterior reversible encephalopathy syndrome during sunitinib therapy.
    Cumurciuc R; Martinez-Almoyna L; Henry C; Husson H; de Broucker T
    Rev Neurol (Paris); 2008; 164(6-7):605-7. PubMed ID: 18565360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tumor lysis syndrome in a patient with a renal carcinoma treated with sunitinib].
    Rodríguez-Reimúndes E; Perazzo F; Vilches AR
    Medicina (B Aires); 2011; 71(2):158-60. PubMed ID: 21550933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recall pneumonitis during systemic treatment with sunitinib.
    Seidel C; Janssen S; Karstens JH; Welte T; Morgan M; Ganser A; Grünwald V
    Ann Oncol; 2010 Oct; 21(10):2119-2120. PubMed ID: 20720089
    [No Abstract]   [Full Text] [Related]  

  • 15. Benefits of pazopanib over sunitinib for renal cell carcinoma.
    Granovetter M
    Lancet Oncol; 2016 Mar; 17(3):e93. PubMed ID: 26853821
    [No Abstract]   [Full Text] [Related]  

  • 16. Osteonecrosis of the jaws in patients assuming bisphosphonates and sunitinib: two case reports.
    Agrillo A; Nastro Siniscalchi E; Facchini A; Filiaci F; Ungari C
    Eur Rev Med Pharmacol Sci; 2012 Jul; 16(7):952-7. PubMed ID: 22953645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pazopanib outscores sunitinib on tolerability.
    Cancer Discov; 2014 Jan; 4(1):OF8. PubMed ID: 24402960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Leg ulcerations and sunitinib].
    Guyot-Caquelin P; Granel-Brocard F; Cuny JF; Trechot P; Spaeth D; Marchal A; Barbaud A; Schmutz JL
    Ann Dermatol Venereol; 2010 Oct; 137(10):626-9. PubMed ID: 20932442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute cardiac failure after sunitinib.
    Machiels JP; Bletard N; Pirenne P; Jacquet L; Bonbled F; Duck L
    Ann Oncol; 2008 Mar; 19(3):597-9. PubMed ID: 18272908
    [No Abstract]   [Full Text] [Related]  

  • 20. Home blood-pressure monitoring in patients receiving sunitinib.
    Azizi M; Chedid A; Oudard S
    N Engl J Med; 2008 Jan; 358(1):95-7. PubMed ID: 18172185
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.